Biotechnology(BK4139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4139 Biotechnology

Not Yet Opened 04-21 16:00:00 EDT

72.06

-0.51

-0.70%

High72.57	Low71.39	Vol660.93M
Open72.56	D1 Closing72.56	Amplitude1.63%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O14.37B	T/O Rate--	Tradable Shares0.00
P/B7.057481	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4139","market":"US","secType":"PLATE","nameCN":"Biotechnology","latestPrice":72.05961,"timestamp":1776801599999,"preClose":72.56461,"halted":0,"volume":660932422,"delay":0,"changeRate":-0.006959,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-0.505005,"latestTime":"04-21 16:00:00 EDT","open":72.56478,"high":72.56637,"low":71.3853,"amount":14369163013.088514,"amplitude":0.016276,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1776864600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":7.057481,"peRate":-214.01139,"turnoverRate":0.019425,"increases":104,"decrements":395,"flats":14,"marketCap":1871468998502.25,"floatMarketCap":1654904092416.1875},"requestUrl":"/m/hq/s/BK4139","defaultTab":"news","newsList":[{"id":"2629319097","title":"Press Release: Samsung Biologics Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2629319097","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629319097?lang=en_us&edition=fundamental","pubTime":"2026-04-22 14:50","pubTimestamp":1776840600,"startTime":"0","endTime":"0","summary":"-- Recorded Q1'26 revenue of KRW 1,257 billion and operating profit of KRW. -- Performance driven by full utilization across Plants 1 through 4 and. INCHEON, South Korea, April 22, 2026 /PRNewswire/ -- Samsung Biologics , a leading contract development and manufacturing organization , reported financial results for the first quarter of fiscal year 2026.In March, Samsung Biologics completed the acquisition of its Rockville manufacturing facility in Maryland, U.S. for USD 353 million, establishing its first U.S. manufacturing presence and further strengthening client proximity and supply chain resilience in a key market. Samsung Biologics also continues to evaluate strategic investments to further diversify its manufacturing network and support clients seeking regional supply alignment amid an evolving global operating env","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","CDMO","CEPI","BK4604","BK4139","BK4504","BK4550","EMXC","BK4585","TM","BK4099","IEMG","03160","BK4555","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629092056","title":"Kyverna Therapeutics (KYTX) Stock Surges 24% After Hours: Why Is It Moving?","url":"https://stock-news.laohu8.com/highlight/detail?id=2629092056","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629092056?lang=en_us&edition=fundamental","pubTime":"2026-04-22 14:44","pubTimestamp":1776840248,"startTime":"0","endTime":"0","summary":"Kyverna Therapeutics Inc. shares surged 24% after hours following positive registrational trial results for miv-cel in stiff person syndrome, showing significant improvement in walking speed.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/04/51960000/kyverna-therapeutics-kytx-stock-surges-24-after-hours-why-is-it-moving","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OPEX","BK4079","BK4150","BK4139","BK4562","BK4561","OPEG","KYTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629709257","title":"SER Industries Gets BSE's Approval for Name Change","url":"https://stock-news.laohu8.com/highlight/detail?id=2629709257","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629709257?lang=en_us&edition=fundamental","pubTime":"2026-04-22 14:28","pubTimestamp":1776839328,"startTime":"0","endTime":"0","summary":"Logistic service provider SER Industries  has received approval from the BSE stock exchange to \"Desi Farms India\" with effect from April 21, according to a same-day filing to the BSE.The company's equity shares will be traded under scrip ID \"DESIFARMS\" with effect from April 27.The company's shares were up 2% in recent trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BSE","BK4139","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629092015","title":"A Look At Ocugen (OCGN) Valuation After Positive OCU410 Phase 2 ArMaDa Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2629092015","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629092015?lang=en_us&edition=fundamental","pubTime":"2026-04-22 14:05","pubTimestamp":1776837909,"startTime":"0","endTime":"0","summary":"Ocugen (OCGN) is back in focus after releasing the full Phase 2 ArMaDa dataset for OCU410, its modifier gene therapy for dry age related macular degeneration, showing a 46% reduction in macular lesion growth.\nSee our latest analysis for Ocugen.\nThe latest OCU410 data arrives after a mixed period for the stock, with a 1 month share price return of negative 13.24% alongside a 90 day gain of 18.79% and a very large 1 year total shareholder return of 157.45%. This suggests momentum has been...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ocgn/ocugen/news/a-look-at-ocugen-ocgn-valuation-after-positive-ocu410-phase","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ocgn/ocugen/news/a-look-at-ocugen-ocgn-valuation-after-positive-ocu410-phase","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4568","OCGN","BK4563","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629099181","title":"EQ Resources Director Granted 5.7 Million Performance Rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2629099181","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629099181?lang=en_us&edition=fundamental","pubTime":"2026-04-22 12:47","pubTimestamp":1776833264,"startTime":"0","endTime":"0","summary":"The latest announcement is out from EQ Resources Limited ( ($AU:EQR) ). EQ Resources Limited has disclosed a change in the securities interests of ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eq-resources-director-granted-5-7-million-performance-rights?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eq-resources-director-granted-5-7-million-performance-rights?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","BK4139","EQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629095835","title":"Arovella Therapeutics Says Shareholder Notice Calling for Director Appointments is Invalid","url":"https://stock-news.laohu8.com/highlight/detail?id=2629095835","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629095835?lang=en_us&edition=fundamental","pubTime":"2026-04-22 11:24","pubTimestamp":1776828296,"startTime":"0","endTime":"0","summary":"Arovella Therapeutics  said a recent notice from shareholder The Trust Company  calling for a general meeting to appoint three directors is considered invalid, according to a Wednesday filing with the Australian bourse.The company disclosed the notice on April 10, saying the shareholder holds more than 5% of voting shares.Arovella Therapeutics said the notice \"cannot be lawfully effected at a general meeting,\" and it has invited the shareholder to formally withdraw the invalid notice.It added that its board has sought to meet with the director nominees, but its requests were declined.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK7096","LENZ","ALA.AU","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629309806","title":"MeiraGTx Holdings Plc : Piper Sandler Raises Target Price to $30 From $26","url":"https://stock-news.laohu8.com/highlight/detail?id=2629309806","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629309806?lang=en_us&edition=fundamental","pubTime":"2026-04-22 10:49","pubTimestamp":1776826189,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nFWN4140OV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MGTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629053098","title":"IDEAYA And AstraZeneca Collaboration Adds New Dimension To IDE849 And Valuation","url":"https://stock-news.laohu8.com/highlight/detail?id=2629053098","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629053098?lang=en_us&edition=fundamental","pubTime":"2026-04-22 10:13","pubTimestamp":1776823987,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences (NasdaqGS:IDYA) has entered a clinical collaboration with AstraZeneca to study IDE849, a DLL3 TOP1 antibody drug conjugate.\nThe program will evaluate IDE849 in combination with Imfinzi in extensive stage small cell lung cancer and other DLL3 upregulated tumors.\n\nFor readers tracking IDEAYA mainly through its uveal melanoma drug darovasertib, this collaboration with AstraZeneca broadens the story. The company, trading at $31.83, has delivered a 70.9% return over the past...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-idya/ideaya-biosciences/news/ideaya-and-astrazeneca-collaboration-adds-new-dimension-to-i","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-idya/ideaya-biosciences/news/ideaya-and-astrazeneca-collaboration-adds-new-dimension-to-i","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","IDYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629098032","title":"The Tactical Trio Blueprint For Solid Balance Sheet And Fundamentals","url":"https://stock-news.laohu8.com/highlight/detail?id=2629098032","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629098032?lang=en_us&edition=fundamental","pubTime":"2026-04-22 10:11","pubTimestamp":1776823873,"startTime":"0","endTime":"0","summary":"With inflation, energy shocks and bond yields all in focus, many investors are looking for companies that are not only surviving the noise but also backed by strong fundamentals. A solid balance sheet and high return on equity can help show which businesses are using capital efficiently while keeping financial risk in check. That is exactly what the Solid Balance Sheet and Fundamentals screener is built to highlight. In this article, you will see three stocks filtered by that approach, along...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/343729-main-header/1756255630650","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/343729-main-header/1756255630650"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/food-beverage-tobacco/nasdaq-mnst/monster-beverage/news/the-tactical-trio-blueprint-for-solid-balance-sheet-and-fund","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/food-beverage-tobacco/nasdaq-mnst/monster-beverage/news/the-tactical-trio-blueprint-for-solid-balance-sheet-and-fund","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","LU1429558221.USD","BK4023","PLTD","LU1435385759.SGD","PLTW","IE00B19Z9P08.USD","PLTZ","LU2326559502.SGD","BK4588","PLYY","LU0234570918.USD","PLOO","PLTG","BK4547","BK4177","BK4504","LU0079474960.USD","LU1035775433.USD","LU1861559042.SGD","IE00B19Z9505.USD","PLTI","BK4533","PTIR","IE00B894F039.SGD","SGXZ51526630.SGD","PLTR","BK4613","LU0342679015.USD","LU0077335932.USD","LU0345770993.USD","BK4543","BK4139","PLTA","PLTY","SGXZ99366536.SGD","EXEL","LU1861558580.USD","PLT","LU0345774391.USD","LU0345774631.USD","MNST","BK4532","PLTU","SGXZ81514606.USD","LU0345770308.USD","IE00B19Z9Z06.USD","LU1069344957.HKD","IE00BZ9MQY76.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629702098","title":"A Look At Nuvalent (NUVL) Valuation As Zidesamtinib NDA Acceptance Advances Late Stage Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2629702098","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629702098?lang=en_us&edition=fundamental","pubTime":"2026-04-22 10:11","pubTimestamp":1776823871,"startTime":"0","endTime":"0","summary":"Nuvalent (NUVL) is back in focus after the FDA accepted its New Drug Application for zidesamtinib in ROS1-positive NSCLC and set a Prescription Drug User Fee Act action date for September 18, 2026.\nSee our latest analysis for Nuvalent.\nThe FDA’s NDA acceptance and upcoming data presentations arrive after a 30-day share price return of 13.04% and a year-to-date share price return of 6.24%, while the 1-year total shareholder return of 50.06% and 3-year total shareholder return above 3x suggest...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nuvl/nuvalent/news/a-look-at-nuvalent-nuvl-valuation-as-zidesamtinib-nda-accept","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nuvl/nuvalent/news/a-look-at-nuvalent-nuvl-valuation-as-zidesamtinib-nda-accept","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SSI","BK4539","DCF","BK4139","NUVL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162282551","title":"Legend Biotech Soars Over 40% in 5 Days: Is Lilly's $7B Bet Revealing a Deeply Undervalued Gem?","url":"https://stock-news.laohu8.com/highlight/detail?id=1162282551","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162282551?lang=en_us&edition=fundamental","pubTime":"2026-04-22 10:04","pubTimestamp":1776823476,"startTime":"0","endTime":"0","summary":"Legend Biotech's stock surged 41.72% over five trading days, a significant rally for a stock that had declined for over six months with a peak-to-trough drop exceeding 60%. This upward movement was...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1804176565.USD","BK4139","LU0114720955.EUR","LU0466842654.USD","LU0289739699.SGD","LU0210536198.USD","LU0417517546.SGD","LU0096364046.USD","LU0133085943.USD","LU2324357040.USD","ELIL","LU1983299246.USD","IE0005OL40V9.USD","SG9999014914.USD","IE00BJJMRY28.SGD","LU0683600562.USD","IE0004445239.USD","LU0097036916.USD","LU0353189680.USD","LU0432979614.USD","IE00BN29S564.USD","LU0256863902.USD","IE00BFSS7M15.SGD","SG9999013999.USD","SG9999001176.SGD","LU0823434740.USD","LU0943347566.SGD","LU1551013342.USD","IE00BJJMRZ35.SGD","SG9999001176.USD","LLYZ","LU2023251221.USD","IE00BFSS8Q28.SGD","LU2264538146.SGD","SG9999015945.SGD","SG9999015978.USD","LU2236285917.USD","LU0882574055.USD","LU1280957306.USD","SG9999015952.SGD","LU2237443549.SGD","LU1145028129.USD","LU2089283258.USD","LU2471134523.USD","SG9999014906.USD","LU2237443465.HKD","LU2552382132.HKD","IE00B775H168.HKD","LU0006306889.USD","LU2750360641.GBP","LU0058720904.USD","IE0002141913.USD","LU0323591593.USD","BK4581","BK4585","SG9999017495.SGD","LU0640476718.USD","LU2756315664.SGD","LU2750360997.AUD","LU2089984988.USD","LU1267930730.SGD","LU0385154629.USD","LU0238689110.USD","LU0354030438.USD","LU0320765992.SGD","LU0689472784.USD","LU1551013425.SGD","LU1712237335.SGD","LU0471298777.SGD","LU2213496289.HKD","LU2265009873.SGD","LU1868837136.USD","LU1974910355.USD","LU2237443978.SGD","LU1232071149.USD","IE00BKPKM429.USD","ELIS","LU2168564149.EUR","LU1868836757.USD","LU1720051017.SGD","LU0823416689.USD","LU1548497426.USD","LU1868837300.USD","IE00BK4W5M84.HKD","LU0158827781.USD","LU2746668974.SGD","LU1323610961.USD","LU1127390331.HKD","LU0471298694.HKD","LU2456880835.USD","LU0106261372.USD","LU0109394709.USD","LU2237438978.USD","LU0094547139.USD","LU2357305700.SGD","LU1093756325.SGD","SGXZ99366536.SGD","LU0820561909.HKD","LU2108987350.USD","LU2491049909.HKD","LU0122379950.USD","LU0158827948.USD","IE00BJT1NW94.SGD","IE00BKDWB100.SGD","LU2168564065.EUR","LU2106854487.HKD","LU2552382215.SGD","LU2361044865.SGD","LU2491050154.USD","LU2468319806.SGD","LU0456855351.SGD","GB00BDT5M118.USD","SG9999014880.SGD","LU2462157665.USD","LU2471134879.HKD","LU1291159041.SGD","LU2168564222.USD","LU1988902786.USD","LU0823434583.USD","LU1093756168.USD","SGXZ51526630.SGD","LU2087625088.SGD","IE00B4JS1V06.HKD","LU2168564495.EUR","LU0234572021.USD","SG9999018865.SGD","LU0225283273.USD","LU0109391861.USD","LU1917777945.USD","LU1989771016.USD","LU2746668461.USD","LU1023059063.AUD","LU1061106388.HKD","LU0820561818.USD","LU1035775433.USD","LU0786609619.USD","BK4534","LU1069344957.HKD","IE00B1XK9C88.USD","BK4505","LU0203202063.USD","BK4007","BK4599","LU2237443895.HKD","LU0061475181.USD","LU2461242641.AUD","LU0266013472.USD","LU0964807845.USD","LU1720051108.HKD","LU0203201768.USD","LU2602419157.SGD","LLYX","LU2271345857.HKD","LU2063271972.USD","LU0889565916.HKD","LU1868836591.USD","LU0787776722.HKD","IE00BJLML261.HKD","LU2361045086.USD","IE00BFTCPJ56.SGD","LU2028103732.USD","BK4533","LEGN","SGXZ31699556.SGD","LU2112291526.USD","IE0009355771.USD","LU1623119135.USD","IE00BK4W5L77.USD","LU0079474960.USD","LU2417539215.USD","LU0320765059.SGD","IE00B7KXQ091.USD","SG9999014898.SGD","LLII","LU0316494557.USD","LU1629891620.HKD","LU0820562030.AUD","LU2089284900.SGD","LU2168563687.JPY","LU2211815571.USD","LU2471134796.USD","LU2471134952.CNY","LU2756315318.SGD","SGXZ57979304.SGD","SGXZ81514606.USD","LU2360106947.USD","IE00BWXC8680.SGD","LU2896262040.SGD","IE0001KFT4U8.USD","LU2361044949.HKD","BK4588","LU0354030511.USD","LU2023250504.SGD","IE00B1BXHZ80.USD","LU2237443382.USD","LU2552382058.USD","LU1064131342.USD","LU1366192091.USD","IE0004445015.USD","BK4516","LU0708995401.HKD","IE00BJJMRX11.SGD","LU0353189763.USD","LU0882574139.USD","LU2111349929.HKD","LU2023250330.USD","LU1057294990.SGD","IE00B2B36J28.USD","LU0672654240.SGD","LU0198837287.USD","LU0256863811.USD","LU1868836914.USD","LU1814569148.SGD","LU2237443622.USD","LU2491050071.SGD","IE00B4R5TH58.HKD","SG9999018857.SGD","SG9999015986.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629098597","title":"Top Incyte Executive Makes Bold Move With Major Stock Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2629098597","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629098597?lang=en_us&edition=fundamental","pubTime":"2026-04-22 10:04","pubTimestamp":1776823459,"startTime":"0","endTime":"0","summary":"New insider activity at Incyte ( ($INCY) ) has taken place on April 21, 2026. Incyte’s President and Global Head of R&D, Pablo Cagnoni, recently un...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-incyte-executive-makes-bold-move-with-major-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-incyte-executive-makes-bold-move-with-major-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4550","BK4139","BK4588","INCY","BK4532","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629209859","title":"Top Cytokinetics Executive Makes Notable Move With Fresh Stock Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2629209859","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629209859?lang=en_us&edition=fundamental","pubTime":"2026-04-22 10:02","pubTimestamp":1776823340,"startTime":"0","endTime":"0","summary":"New insider activity at Cytokinetics ( ($CYTK) ) has taken place on April 21, 2026. Cytokinetics has seen insider activity as EVP of Research & Dev...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-cytokinetics-executive-makes-notable-move-with-fresh-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-cytokinetics-executive-makes-notable-move-with-fresh-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CYTK","BK4588","BK4505","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629060299","title":"Protagonist Therapeutics Insider Move: CFO Cashes In on a Notable Stock Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2629060299","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629060299?lang=en_us&edition=fundamental","pubTime":"2026-04-22 10:01","pubTimestamp":1776823301,"startTime":"0","endTime":"0","summary":"New insider activity at Protagonist Therapeutics ( ($PTGX) ) has taken place on April 21, 2026. CFO Asif Ali of Protagonist Therapeutics has recent...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/protagonist-therapeutics-insider-move-cfo-cashes-in-on-a-notable-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/protagonist-therapeutics-insider-move-cfo-cashes-in-on-a-notable-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629060229","title":"Major Insider Move Rocks Vor Biopharma as Director Unloads Massive Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2629060229","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629060229?lang=en_us&edition=fundamental","pubTime":"2026-04-22 10:01","pubTimestamp":1776823268,"startTime":"0","endTime":"0","summary":"New insider activity at Vor Biopharma ( ($VOR) ) has taken place on April 21, 2026. Director Ra Capital Management, LLC has executed a major move i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-insider-move-rocks-vor-biopharma-as-director-unloads-massive-stake-insider-trading-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-insider-move-rocks-vor-biopharma-as-director-unloads-massive-stake-insider-trading-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","VOR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629060589","title":"CSL (CMXHF) Gets a Hold from Ord Minnett","url":"https://stock-news.laohu8.com/highlight/detail?id=2629060589","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629060589?lang=en_us&edition=fundamental","pubTime":"2026-04-22 09:36","pubTimestamp":1776821809,"startTime":"0","endTime":"0","summary":"In a report released today, from Ord Minnett maintained a Hold rating on CSL, with a price target of A$186.00. In addition to Ord Minnett, CSL also...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/csl-cmxhf-gets-a-hold-from-ord-minnett-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/csl-cmxhf-gets-a-hold-from-ord-minnett-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CSL","BK4139","SG9999004303.SGD","LU1169590202.USD","CMXHF","BK4086","LU1169589451.USD","SGXZ23171101.USD","LU0728928796.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629062784","title":"Natera co-founder, director Sheena Jonathan disposes of $299,441 common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2629062784","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629062784?lang=en_us&edition=fundamental","pubTime":"2026-04-22 09:05","pubTimestamp":1776819946,"startTime":"0","endTime":"0","summary":"Natera director and co-founder Sheena Jonathan reported sales of 1,500 Natera common shares on April 17.Shares were sold at weighted average prices of $199.66 and $199.59.Transactions were reported as indirect holdings through Caraluna 1 Trust and Caraluna 2 Trust.Each trust reported 20,282 Natera common shares held following the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Natera Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 21, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL7M4T4f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Natera co-founder, director Sheena Jonathan disposes of $299,441 common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345770308.USD","LU0012050646.USD","LU2264538146.SGD","LU0106261612.USD","LU0053671581.USD","LU1988902786.USD","LU0345770993.USD","LU1064131342.USD","LU0963586101.USD","LU2065171311.SGD","LU2065731478.USD","LU2324357040.USD","NTRA","LU2065171402.SGD","LU2065170008.USD","LU2065169927.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629062473","title":"MeiraGTx CFO, COO Richard Giroux disposes 56,000 shares for $572,320","url":"https://stock-news.laohu8.com/highlight/detail?id=2629062473","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629062473?lang=en_us&edition=fundamental","pubTime":"2026-04-22 09:02","pubTimestamp":1776819722,"startTime":"0","endTime":"0","summary":"MeiraGTx CFO and COO Richard Giroux sold 56,000 ordinary shares on April 21, 2026 at a weighted average price of $10.22.Direct holdings fell to 971,530 ordinary shares following transaction.Giroux also reported indirect beneficial ownership of 5,152 ordinary shares held by spouse.Indirect holdings included 85,000 ordinary shares held by Aigle Healthcare Partners III LLC.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MeiraGTx Holdings plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 21, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDLxfFgF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"MeiraGTx CFO, COO Richard Giroux disposes 56,000 shares for $572,320","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629062322","title":"Sionna director Peter A. Thompson disposes of USD 2.5 million common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2629062322","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629062322?lang=en_us&edition=fundamental","pubTime":"2026-04-22 08:43","pubTimestamp":1776818586,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics director Peter A. Thompson reported sales of common stock on April 17-18.Transaction totaled 55,345 shares at prices of USD 44.52 to USD 44.68.Beneficial ownership following transactions was 2,964,774 shares held indirectly.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sionna Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 21, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL8TVmL0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629314062","title":"OrbiMed Advisors reports Sionna Therapeutics common stock disposal worth $2.5 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2629314062","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629314062?lang=en_us&edition=fundamental","pubTime":"2026-04-22 08:40","pubTimestamp":1776818454,"startTime":"0","endTime":"0","summary":"OrbiMed Advisors LLC, director, sold 55,345 shares of Sionna Therapeutics common stock on April 17-18.Sales were reported at prices of USD 44.68, USD 44.52.Indirect beneficial ownership following transactions was 2,964,774 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sionna Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 21, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL6FbmBm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"OrbiMed Advisors reports Sionna Therapeutics common stock disposal worth $2.5 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SION"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0139},{"period":"1month","weight":0.0856},{"period":"3month","weight":0.0273},{"period":"6month","weight":0.0481},{"period":"1year","weight":0.3701},{"period":"ytd","weight":0.0325}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4139","nameEN":"BK4139"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biotechnology(BK4139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Biotechnology(BK4139) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Biotechnology,BK4139,Biotechnology股票,Biotechnology股票老虎,Biotechnology股票老虎国际,Biotechnology行情,Biotechnology股票行情,Biotechnology股价,Biotechnology股市,Biotechnology股票价格,Biotechnology股票交易,Biotechnology股票购买,Biotechnology股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biotechnology(BK4139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Biotechnology(BK4139) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}